ListedSMEPharmaceuticals & DrugsONYX
Onyx Biotec IPO
Onyx Biotec IPO is a sme IPO raising ₹29 Cr at ₹58 – ₹61 a share. It listed on 22 Nov 2024 and trades at ₹41 today, −33.1% against its issue price of ₹61. It was subscribed 0.00× in total.
₹61
Issue price
₹41
Price now
−33.1%
Since issue price
22 Nov 2024
Listed on
0.00×Subscribed (final) · all exchanges
No bids yet
populated partly populated we hold nothing here — the tab says why
Who bid for it
| Investor category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| QIB Banks, funds and other large institutions | 0 | 2,96,34,000 | 0.00× |
| Foreign Institutional Investors | no separate quota | 1,20,62,000 | n/a |
| Domestic Financial Institutions | no separate quota | 34,18,000 | n/a |
| Mutual funds | no separate quota | 0 | n/a |
| Others | no separate quota | 1,41,54,000 | n/a |
| Non-institutional Wealthy individuals and companies bidding above ₹2 lakh | 0 | 41,51,66,000 | 0.00× |
| Corporates | no separate quota | 1,18,86,000 | n/a |
| Individuals | no separate quota | 39,98,80,000 | n/a |
| others | no separate quota | 34,00,000 | n/a |
| Retail Ordinary investors bidding up to ₹2 lakh | 0 | 19,09,78,000 | 0.00× |
| Cut Off | no separate quota | 12,81,62,000 | n/a |
| Price bids | no separate quota | 6,28,16,000 | n/a |
| Total | 0 | 63,57,78,000 | 0.00× |
Sub-categories read no separate quota rather than a dash: the exchange publishes bids at that level but never a reservation against them, so a subscription multiple does not exist — it is not missing data. Bids across both exchanges (NSE and BSE) — the figure usually quoted publicly. Last updated 25 Jul, 06:37 pm IST.
How demand built
Only one reading so far. We sample subscription every hour and store it whenever it moves, so this becomes a curve as bidding runs.